BD BACTEC Blood Culture Bottle Shortage

Click here to watch the recording from the July 23, 2024 webinar.
 
The U.S. is experiencing interruptions in the supply of BD BACTEC blood culture media bottles because of recent supplier issues. The disruption in supply is expected to impact patient diagnosis, follow up patient management, and antimicrobial stewardship efforts. In this webinar, presenters provide an update on the blood culture media bottle shortage, and strategies will be discussed to prioritize the use of supply based on clinical need. 
 
SHEA has been in consistent communication with organizational leadership, BD, FDA, CDC, and the provider community including IDSA and ASM. We’ve collaborated with these partners to compile and share resources to support healthcare facilities through the shortage period.
 

Introductions

Moderator: Dana S. Wollins, DrPH, MGC
Senior Vice President, Strategy, IDSA

 Topics

  • BD Update 
    Chris Beddard, VP, Microbiology, BD Life Sciences
    VP, Global Platform Leader, Microbiology Diagnostic Solutions 
     
  • CDC Blood Culture Quality Tools 
    Jake D. Bunn, MBA, MLS (ASCP)CM, LSSBB 
    Clinical Laboratory Scientist, Division of Laboratory Systems 
    U.S. Centers for Disease Control and Prevention 
     
  • Blood Culture Utilization 
    Valeria Fabre, MD, Associate Professor of Medicine, Division of Infectious Diseases
    Associate Medical Director, Antimicrobial Stewardship Program 
    Associate Hospital Epidemiologist, The Johns Hopkins Hospital 

    Sarah Turbett, MD, Instructor of Medicine, Harvard Medical School 
    Assistant Director, Clinical Microbiology Laboratories 
    Assistant in Medicine, Infectious Diseases, Massachusetts General Hospital 

    Amanda Harrington, PhD, D(ABMM) 
    Director, Clinical Microbiology Laboratory 
    Loyola University Medical Center

Q&A and Discussion - All speakers plus: 

Carl Newman, Deputy Director, Office of Supply Chain Resilience 
U.S. Food and Drug Administration 
 
Ryan Lupert, JD, Regulatory Counsel, Acting Deputy Office Director
for Patient Safety and Product Quality, U.S. Food and Drug Administration